Skip to content

Clinical trials

Phase 3 Recurrence trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 3 Country / region: South Korea Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20103
20112
20122
20144
20155
20171
20181
20191
20211
20221
20234
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting7
Recruiting6
Terminated6
Withdrawn4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.3
Pfizer3
Seoul National University Hospital3
AstraZeneca2
Celgene2
Novartis Pharmaceuticals2
Regeneron Pharmaceuticals2
AVEO Pharmaceuticals, Inc.1
AbbVie1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence34
Multiple Myeloma7
Neoplasms4
Breast Neoplasms3
Demyelinating Diseases3
Lymphoma, Follicular3
Myelitis, Transverse3
Neoplasm Metastasis3
Neuromyelitis Optica3
Optic Neuritis3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.